C6orf163: A Potential Drug Target and Biomarker for Chromosome 6 Open Reading Frame 163

Target Name: C6orf163

NCBI ID: G206412

C6orf163

Other Name(s): Chromosome 6 open reading frame 163 | CF163_HUMAN | Uncharacterized protein C6orf163 | chromosome 6 open reading frame 163

C6orf163: A Potential Drug Target and Biomarker for Chromosome 6 Open Reading Frame 163

Chromosome 6 (C6) is one of the chromosomes responsible for carrying genetic information in the human body. It is home to numerous genes, including the open reading frame (ORF) 163 gene, which is a potential drug target and biomarker for various diseases. ORF 163 is a 192 base pair gene that is located on C6 chromosome at position 68.8 kb. In this article, we will discuss the ORF 163 gene, its potential as a drug target, and its potential as a biomarker for various diseases.

Potential Drug Target

ORF 163 is a gene that encodes a protein known as ORF163p. The ORF163p protein is a 21 kDa protein that is involved in various cellular processes, including cell signaling, protein-protein interactions, and DNA replication. ORF163p has been shown to play a role in the regulation of cell growth, apoptosis, and translation.

ORF163p has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, ORF163p has been shown to be involved in the development of neurofibrillary tangles in Alzheimer's disease and in the regulation of the transition from pro-inflammatory to anti-inflammatory states in stress-induced anxiety.

Potential Biomarker

ORF163 has also been shown to be a potential biomarker for various diseases. For example, ORF163 has been shown to be elevated in the blood samples of patients with Alzheimer's disease, which suggests that it may be a useful biomarker for this disease. Additionally, ORF163 has been shown to be elevated in the blood samples of patients with depression, which suggests that it may be a useful biomarker for this disease.

ORF163 has also been shown to be elevated in the blood samples of patients with various other psychiatric disorders, including anxiety and schizophrenia. This suggests that ORF163 may be a useful biomarker for these disorders as well.

Conclusion

In conclusion, ORF163 is a gene that encodes a protein that is involved in various cellular processes and has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ORF163 has also been shown to be a potential drug target and biomarker for these diseases. Further research is needed to fully understand the role of ORF163 in these diseases and to develop effective treatments.

Protein Name: Chromosome 6 Open Reading Frame 163

The "C6orf163 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C6orf163 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets